A detailed history of Callan Family Office, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Callan Family Office, LLC holds 22,414 shares of PFE stock, worth $599,126. This represents 0.04% of its overall portfolio holdings.

Number of Shares
22,414
Holding current value
$599,126
% of portfolio
0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$24.8 - $30.19 $555,867 - $676,678
22,414 New
22,414 $595 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $1,155 - $1,337
-32 Reduced 0.46%
6,957 $255 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $2,639 - $3,435
67 Added 0.97%
6,989 $285 Million
Q4 2022

Feb 23, 2023

BUY
$41.75 - $54.5 $288,993 - $377,249
6,922 New
6,922 $355 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Callan Family Office, LLC Portfolio

Follow Callan Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Family Office, LLC with notifications on news.